Financials data is unavailable for this security.
View more
Year on year Orchid Pharma Ltd grew revenues 23.05% from 6.66bn to 8.19bn while net income improved 98.99% from 463.18m to 921.67m.
Gross margin | 40.67% |
---|---|
Net profit margin | 12.78% |
Operating margin | 9.88% |
Return on assets | -- |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, cash reserves at Orchid Pharma Ltd fell by 189.96m. Cash Flow from Financing totalled 1.67bn or 20.39% of revenues. In addition the company generated 1.26bn in cash from operations while cash used for investing totalled 3.12bn.
Cash flow per share | 30.05 |
---|---|
Price/Cash flow per share | 47.13 |
Book value per share | -- |
---|---|
Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
Current ratio | -- |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼